LAST 10 YEARS
Funding
Crosstalk among ERalpha, ERbeta and GPER in pancreatic beta-cells and its role in K+-channels regulation and apoptosis induced by environmental estrogens
Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación. 01/09/2021- 28/02/2025.
PIs: Angel Nadal and Juan Martínez-Pinna.
Regulation of pancreatic β- and α-cell viability and function by estrogen receptors ERβ and GPER: role in diabetes mellitus therapy
Programa de Excelencia PROMETEO, Generalitat Valenciana. 01/01/2020 -31/12/2023
PI: Angel Nadal
Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Chemicals (GOLIATH).
European Commission H2020. 01/01/2019-31/12/2024.
PI: Angel Nadal
Actions of simoultaneous exposure to endocrine disruptors and high fat diet on pancreatic beta-cell and risk of type-2 diabetes mellitus
Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación. 01/01/2017-31/12/2020.
PI: Angel Nadal
Effects of maternal estrogenic environment on pancreatic beta cell mass and function in offspring: implications in the etiology of type-2 diabetes
Ministerio de Economía y Competitividad. 01/01/2015- 31/12/2017.
PI: Angel Nadal
Role of estrogen receptors in the regulation of pancreatic beta- and alpha-cell mass during pregnancy
Programa de Excelencia PROMETEO, Generalitat Valenciana. 01/01/2015-31/12/2018.
PI: Angel Nadal
Bisphenol-A effects on glucose homeostasis, islet function and insulin signaling in mice
Ministerio de Ciencia e Innovación. 01/01/2012-30/06/2015.
PI: Angel Nadal
Characterization of the rapid insulinotropic effect of specific estrogen receptor beta agonists: implications for the treatment of diabetes
Programa de Excelencia PROMETEO, Generalitat Valenciana. 01/01/2011-31/12/2014.
PI: Angel Nadal